跳至主要内容
临床试验/CTRI/2024/01/061394
CTRI/2024/01/061394尚未招募Phase 3 4

A Single Arm Prospective Clinical Study on Effect of Vyoshadi Guggulu on Dhatu Pradoshaja Vikaras wsr to Uterine Fibroids

Dr Iram Sayed1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年1月20日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
Vyoshadi guggulu is Effective in management of Uterine Fibroids given orally everyday for 3 consecutive mnths assessed every month symptomatically n final outcome after 3 months

研究概览

简要总结

Uterine Fibroids is major findings in the sonographic findings of many women as a gynacological flaw disturbing their menstrual cycle in many which is becoming a major obstacle in women health nowadays. Surgery for very small fibroids or in young unmarried or nulliparous women is a topic of worry for many women. So This trial is proposed to see the effect of Vyoshadi Guggulu given orally for a period of 3 consecutive months for the management of Uterine Fibroids.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
Female

入选标准

  • 1.Pt having single or multiple Uterine Fibroids of less than 5cms.

排除标准

  • 1.Patient having fibroid of size more than 5 cm as per USG report.
  • 2.Ovarian tumour, tubo-ovarian mass and malignant tumours along with fibroid.
  • 3.Prediagnosed Cases of Cancer.
  • 4.Patient below the age of 20 years and above the age of 50years.
  • 5.Women with Hb < 7 gm%.
  • 6.Pregnant women with fibroid.

结局指标

主要结局

Vyoshadi guggulu is Effective in management of Uterine Fibroids given orally everyday for 3 consecutive mnths assessed every month symptomatically n final outcome after 3 months

时间窗: Monthly

次要结局

  • Vyoshadi Guggulu Does not have any role in management of Uterine Fibroids(Monthly)

研究者

发起方
Dr Iram Sayed
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Iram Bano Mohammed Tarique Sayed

APMs Ayurved Mahavidyalaya, Sion

研究点 (1)

Loading locations...

相似试验